U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285 books (1464 items)

2.
StatPearls [Internet].

StatPearls [Internet].

Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

3.
Endotext [Internet].

Endotext [Internet].

Feingold KR, Adler RA, Ahmed SF, et al., editors.

South Dartmouth (MA): MDText.com, Inc.; 2000-.

4.
LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

LiverTox®: Clinical and Research Information on Drug-Induced Liver Injury [Internet].

Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.

5.
Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT.

Simvastatin to reduce pulmonary dysfunction in patients with acute respiratory distress syndrome: the HARP-2 RCT.

McAuley DF, Laffey JG, O’Kane CM, et al.

Southampton (UK): NIHR Journals Library; 2018 Jan. (Efficacy and Mechanism Evaluation, No. 5.1.)

6.
Therapeutics Letter.

Therapeutics Letter.

Perry T, editor.

Vancouver (BC): Therapeutic Initiatives; 1994-.

7.
8.
Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Screening for Lipid Disorders in Children and Adolescents: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Guirguis-Blake JM, Evans CV, Coppola EL, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2023 Jul. (Evidence Synthesis, No. 229.)

9.
Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs.

Defining phenotypes and treatment effect heterogeneity to inform acute respiratory distress syndrome and sepsis trials: secondary analyses of three RCTs.

Shankar-Hari M, Santhakumaran S, Prevost AT, et al.

Southampton (UK): NIHR Journals Library; 2021 Jul. (Efficacy and Mechanism Evaluation, No. 8.10.)

10.
11.
Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force [Internet].

Patnode CD, Perdue LA, Rossom RC, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. (Evidence Synthesis, No. 189.)

12.
GeneReviews® [Internet].

GeneReviews® [Internet].

Adam MP, Bick S, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2026.

13.
Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation.

Elucigene FH20 and LIPOchip for the Diagnosis of Familial Hypercholesterolaemia: A Systematic Review and Economic Evaluation.

Sharma P, Boyers D, Boachie C, et al.

Southampton (UK): NIHR Journals Library; 2012 Mar. (Health Technology Assessment, No. 16.17.)

14.
Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia [Internet].

Interventions to Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia [Internet].

Kane RL, Butler M, Fink HA, et al.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Mar. (Comparative Effectiveness Reviews, No. 188.)

15.
17.
Medical Genetics Summaries [Internet].

Medical Genetics Summaries [Internet].

Pratt VM, Scott SA, Pirmohamed M, et al., editors.

Bethesda (MD): National Center for Biotechnology Information (US); 2012-.

18.
Description and Analysis of the VA National Formulary.

Description and Analysis of the VA National Formulary.

Institute of Medicine (US) VA Pharmacy Formulary Analysis Committee; Blumenthal D, Herdman R, editors.

Washington (DC): National Academies Press (US); 2000.

19.
Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022: Issue Brief [Internet].

Generic Drug Utilization and Spending Among Medicare Part D Enrollees in 2022: Issue Brief [Internet].

Feyman Y, Sayed B, Finegold K, et al.

Washington (DC): Office of the Assistant Secretary for Planning and Evaluation (ASPE); 2024 Mar 7.

20.
Evidence reviews for the investigation, management and follow-up of glioma: Brain tumours (primary) and brain metastases in adults: Evidence Report A.

Evidence reviews for the investigation, management and follow-up of glioma: Brain tumours (primary) and brain metastases in adults: Evidence Report A.

National Guideline Alliance (UK).

London: National Institute for Health and Care Excellence (NICE); 2018 Jul. (NICE Guideline, No. 99.)

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Images search in Bookshelf

  • Figure G-10
  • Figure G-40
  • Figure G-13
  • Figure G-26
See more (48)...

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...